Vai al contenuto principale della pagina

Drug-Acceptor Interactions : Modeling Theoretical Tools to Test and Evaluate Experimental Equilibrium Effects



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Bindslev Niels Visualizza persona
Titolo: Drug-Acceptor Interactions : Modeling Theoretical Tools to Test and Evaluate Experimental Equilibrium Effects Visualizza cluster
Pubblicazione: Co-Action Publishing
Boca Raton, FL : , : CRC Press, , 2017
Edizione: First edition.
Descrizione fisica: 1 online resource (798 pages) : illustrations
Disciplina: 615.7045
Soggetto topico: Drug interactions
Chemotherapy
Soggetto non controllato: Drugs
therapy
Note generali: Bibliographic Level Mode of Issuance: Monograph
Nota di bibliografia: Includes bibliographical references at the end of each chapters.
Sommario/riassunto: "Drug-Acceptor Interactions: Modeling theoretical tools to test and evaluate experimental equilibrium effects suggests novel theoretical tools to test and evaluate drug interactions seen with combinatorial drug therapy. The book provides an in-depth, yet controversial, exploration of existing tools for analysis of dose-response studies at equilibrium or steady state. The book is recommended reading for post-graduate students and researchers engaged in the study of systems biology, networks, and the pharmacodynamics of natural or industrial drugs, as well as for medical clinicians interested in drug application and combinatorial drug therapy. Even people without mathematical skills will be able to follow the pros and cons of reaction schemes and their related distribution equations. Chapter 9 is a hands-on guide for software to plot, fit and analyze one's own data."--Provided by publisher.
Titolo autorizzato: Drug-Acceptor Interactions  Visualizza cluster
ISBN: 1-351-66057-8
1-315-15978-3
1-351-66058-6
91-977071-1-2
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910139090703321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui